XML 29 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Cash, Cash Equivalents, Restricted Cash and Marketable Securities
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Marketable Securities
4.
Cash and Cash Equivalents, Restricted Cash and Marketable Securities

The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):

 

 

 

December 31

 

 

 

2022

 

 

2021

 

 

2020

 

Cash and cash equivalents

 

$

202,004

 

 

$

436,189

 

 

$

32,073

 

Restricted cash

 

 

207

 

 

 

219

 

 

 

237

 

Total cash and cash equivalents, and restricted cash shown in the
   consolidated statements of cash flows

 

$

202,211

 

 

$

436,408

 

 

$

32,310

 

Restricted cash balances relate to certificates of deposit issued as collateral to certain letters of credit issued as security to our lease arrangements (See Note 8).

Cash and cash equivalents, and marketable securities consist of the following (in thousands):

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

29,586

 

 

$

-

 

 

$

-

 

 

$

29,586

 

Money market funds

 

 

172,418

 

 

 

-

 

 

 

-

 

 

 

172,418

 

Total cash and cash equivalents

 

 

202,004

 

 

 

-

 

 

 

-

 

 

 

202,004

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

 

42,502

 

 

 

-

 

 

 

(194

)

 

 

42,308

 

U.S. government agency securities

 

 

88,429

 

 

 

-

 

 

 

(397

)

 

 

88,032

 

Corporate debt securities

 

 

292,865

 

 

 

12

 

 

 

(826

)

 

 

292,051

 

Total marketable securities available-for-sale

 

 

423,796

 

 

 

12

 

 

 

(1,417

)

 

 

422,391

 

Total cash and cash equivalents, and marketable securities

 

$

625,800

 

 

$

12

 

 

$

(1,417

)

 

$

624,395

 

December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

6,995

 

 

$

-

 

 

$

-

 

 

$

6,995

 

Money market funds

 

 

429,194

 

 

 

-

 

 

 

-

 

 

 

429,194

 

Total cash and cash equivalents

 

 

436,189

 

 

 

-

 

 

 

-

 

 

 

436,189

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

 

4,005

 

 

 

-

 

 

 

(1

)

 

 

4,004

 

U.S. government agency securities

 

 

26,555

 

 

 

-

 

 

 

(7

)

 

 

26,548

 

Corporate debt securities

 

 

79,200

 

 

 

9

 

 

 

-

 

 

 

79,209

 

Total marketable securities available-for-sale

 

 

109,760

 

 

 

9

 

 

 

(8

)

 

 

109,761

 

Total cash and cash equivalents, and marketable securities

 

$

545,949

 

 

$

9

 

 

$

(8

)

 

$

545,950

 

 

The maturities of our marketable securities available-for-sale are as follows (in thousands):

 

.

 

December 31, 2022

 

 

 

Amortized
Cost

 

 

Estimated
Fair Value

 

Mature in one year or less

 

$

367,013

 

 

$

365,709

 

Mature after one year through two years

 

 

56,783

 

 

 

56,682

 

 

 

$

423,796

 

 

$

422,391

 

 

There were no realized gains or losses from the sale of marketable securities for each of the years ended December 31, 2022 and 2021. There were no investments with unrealized losses longer than 12 months as of December 31, 2022. We do not intend to sell, and are not required to sell, the investments that are in an unrealized loss position before recovery of their amortized cost basis. As such, there have been no declines in fair value that have been identified as other than temporary.